Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TEG 6s Hemostasis System

K-Number: K160502 · 2017-04-19

Decision Date2017-04-19
Product CodeJPA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

TEG 6s Hemostasis System is the device name listed in this FDA 510(k) record. The listed applicant is Haemonetics Corporation. It received FDA 510(k) clearance on 2017-04-19 under 510(k) number K160502. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TEG 6s Hemostasis System?

TEG 6s Hemostasis System is a medical device that received FDA 510(k) clearance on 2017-04-19. The listed applicant is Haemonetics Corporation. The 510(k) number is K160502.

When did TEG 6s Hemostasis System receive FDA 510(k) clearance?

TEG 6s Hemostasis System received FDA 510(k) clearance on 2017-04-19, under 510(k) number K160502.

Who is the listed applicant for TEG 6s Hemostasis System?

The FDA 510(k) record lists Haemonetics Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TEG 6s Hemostasis System?

The FDA product code for TEG 6s Hemostasis System is JPA.

Other records listing Haemonetics Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 8 devices →

Related Devices (Code: JPA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.